sprite-preloader
Anzeige
Mehr »
Dienstag, 23.05.2017 Börsentäglich über 12.000 News von 572 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von BioPharma-Reporter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
14:20Amgen: Bioprocess intensification and integration key for next-generation manufacturing
MoAduro and Merck & Co to test Keytruda and CRS-207 in second cancer study
FrThe automation generation: Sartorius integrates analytics tech
FrNovartis in Switzerland: Biologics job boost but 500 'traditional' jobs to go
FrDr Reddy's turns to single-use for biosimilar production in India
FrTherachon hires Catalent to make protein dwarfism drug for Ph I trial
MiA happy medium for stem cells? Irvine Scientific launches GMP xeno-free offering
Mi'Dual-warhead' a key differentiator for ADCs, says Synaffix
MiThermo Fisher: $7.2bn Patheon sits in sweet spot for bioproduction business
16.05.Boehringer Ingelheim opens Shanghai contract biomanufacturing plant
16.05.Single-use making its mark in India as Stelis teams with MilliporeSigma
16.05.Consolidated vaccine sector urgently needs a workforce booster shot, Sanofi
16.05.Norgine increases portfolio in Merus acquisition
15.05.How Thermo Fisher buying Patheon could simplify pharma supply chains
12.05.Seven-year switch? Formycon bets on third wave biosimilars with Stelara candidate
12.05.Takeda teams with GammaDelta to develop novel cell therapies
12.05.Avantor to spend $6.4bn on VWR acquisition
12.05.Vision on the Horizon: Horizon Pharma acquires River Vision's Thyroid Eye Disease mAb
12.05.Pfizer expands hemophilia gene therapy pipeline with $720m Sangamo deal
12.05.Glenmark eyes up 1,000L production line expansion at Swiss plant
10.05.Industry 4.0 making its mark in biomanufacturing sector, Thermo Fisher
10.05.Irish ayes: Lilly goes ahead with bioproduction expansion, adding 130 jobs
10.05.Biosimilars in Europe: 11 years, 28 approvals, 0 safety concerns
10.05.Brammer invests in commercial-ready gene therapies
09.05.Amgen funds development of intracellular drugs